.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 8,067,449

« Back to Dashboard

Details for Patent: 8,067,449

Title:Modulators of pharmacokinetic properties of therapeutics
Abstract: The present application provides for a compound of Formula I, or a pharmaceutically acceptable salt, solvate, and/or ester thereof, compositions containing such compounds, therapeutic methods that include the administration of such compounds, and therapeutic methods and include the administration of such compounds with at least one additional therapeutic agent. ##STR00001##
Inventor(s): Desai; Manoj C. (Pleasant Hill, CA), Hong; Allen Y. (Pasadena, CA), Liu; Hongtao (Cupertino, CA), Vivian; Randall W. (San Mateo, CA), Xu; Lianhong (Palo Alto, CA)
Assignee: Gilead Sciences, Inc. (Foster City, CA)
Filing Date:Jul 06, 2007
Application Number:12/306,198
Claims:1. A compound of formula IIA: ##STR00234## or a pharmaceutically acceptable salt, stereoisomer and/or ester thereof, wherein: R.sup.11 and R.sup.16 are each independently heterocyclyl or substituted heterocyclyl; R.sup.12, R.sup.14, and R.sup.15 are each independently H, --C.sub.1-4 alkyl, --C.sub.1-4 substituted alkyl, arylalkyl, or substituted arylalkyl; R.sup.13 is --(CH.sub.2).sub.0-1CR.sup.17R.sup.18OR.sup.19; R.sup.17 and R.sup.18 are each independently H or --C.sub.1-3 alkyl; and R.sup.19 is H, --C.sub.1-4 alkyl or arylalkyl.

2. The compound of claim 1 which is a compound selected from the group consisting of: ##STR00235## ##STR00236## ##STR00237## ##STR00238## ##STR00239## and pharmaceutically acceptable salts, esters, and/or stereoisomers thereof.

3. A pharmaceutical composition comprising a compound formula IIA or a pharmaceutically acceptable salt, stereoisomer and/or ester thereof, as described in claim 1, and a pharmaceutically acceptable carrier or excipient.

4. A pharmaceutical composition comprising a compound formula IIA or a pharmaceutically acceptable salt, stereoisomer and/or ester thereof, as described in claim 2, and a pharmaceutically acceptable carrier or excipient.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc